Home
/
iSpecimen Inc.
/
Financials
/
Quarterly
iSpecimen Inc. — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that iSpecimen Inc. filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$106.6K
Nov 17, 2025
Q2
2025
Jun 30, 2025
$713.1K
Aug 14, 2025
Q1
2025
Mar 31, 2025
$1.06M
May 19, 2025
Q3
2025
Sep 30, 2024
$2.66M
Nov 17, 2025
Q2
2025
Jun 30, 2024
$2.86M
Aug 14, 2025
Q1
2025
Mar 31, 2024
$2.29M
May 19, 2025
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2024
Sep 30, 2024
$2.66M
Nov 7, 2024
Q2
2024
Jun 30, 2024
$2.86M
Aug 6, 2024
Q1
2024
Mar 31, 2024
$2.29M
May 7, 2024
Q3
2024
Sep 30, 2023
$2.78M
Nov 7, 2024
Q2
2024
Jun 30, 2023
$1.63M
Aug 6, 2024
Q1
2024
Mar 31, 2023
$2.95M
May 7, 2024
Q3
2023
Sep 30, 2022
$2.58M
Nov 2, 2023
Q2
2023
Jun 30, 2022
$2.34M
Aug 2, 2023
Q1
2023
Mar 31, 2022
$2.52M
May 4, 2023
Q3
2022
Sep 30, 2021
$2.72M
Nov 8, 2022
Q2
2022
Jun 30, 2021
$2.90M
Aug 4, 2022
Q1
2022
Mar 31, 2021
$2.96M
May 10, 2022
Q3
2021
Sep 30, 2020
$2.25M
Nov 4, 2021
Q2
2021
Jun 30, 2020
$1.50M
Aug 10, 2021
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($2.78M)
Nov 17, 2025
Q3
2025
Jun 30, 2025
($1.05M)
Nov 17, 2025
Q2
2025
Jun 30, 2025
($1.05M)
Aug 14, 2025
Q2
2025
Mar 31, 2025
($1.66M)
Aug 14, 2025
Q1
2025
Mar 31, 2025
($1.66M)
May 19, 2025
Q3
2025
Mar 31, 2025
($1.66M)
Nov 17, 2025
Q3
2025
Sep 30, 2024
($1.44M)
Nov 17, 2025
Q2
2025
Jun 30, 2024
($2.11M)
Aug 14, 2025
Q3
2025
Jun 30, 2024
($2.11M)
Nov 17, 2025
Q2
2025
Mar 31, 2024
($2.90M)
Aug 14, 2025
Q3
2025
Mar 31, 2024
($2.90M)
Nov 17, 2025
Q1
2025
Mar 31, 2024
($2.90M)
May 19, 2025
Q3
2024
Sep 30, 2023
($2.11M)
Nov 7, 2024
Q3
2024
Jun 30, 2023
($3.48M)
Nov 7, 2024
Q2
2024
Jun 30, 2023
($3.48M)
Aug 6, 2024
Q1
2024
Mar 31, 2023
($2.43M)
May 7, 2024
Q2
2024
Mar 31, 2023
($2.43M)
Aug 6, 2024
Q3
2024
Mar 31, 2023
($2.43M)
Nov 7, 2024
Q3
2023
Sep 30, 2022
($3.10M)
Nov 2, 2023
Q3
2023
Jun 30, 2022
($2.61M)
Nov 2, 2023
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($2.83M)
Nov 17, 2025
Q2
2025
Jun 30, 2025
($1.82M)
Aug 14, 2025
Q1
2025
Mar 31, 2025
($1.64M)
May 19, 2025
Q3
2025
Sep 30, 2024
($1.71M)
Nov 17, 2025
Q2
2025
Jun 30, 2024
($2.18M)
Aug 14, 2025
Q1
2025
Mar 31, 2024
($3.00M)
May 19, 2025
Q3
2024
Sep 30, 2023
($2.19M)
Nov 7, 2024
Q2
2024
Jun 30, 2023
($3.56M)
Aug 6, 2024
Q1
2024
Mar 31, 2023
($2.54M)
May 7, 2024
Q3
2023
Sep 30, 2022
($3.10M)
Nov 2, 2023
Q2
2023
Jun 30, 2022
($2.59M)
Aug 2, 2023
Q1
2023
Mar 31, 2022
($2.36M)
May 4, 2023
Q3
2022
Sep 30, 2021
($1.46M)
Nov 8, 2022
Q2
2022
Jun 30, 2021
($1.53M)
Aug 4, 2022
Q1
2022
Mar 31, 2021
($942.6K)
May 10, 2022
Q3
2021
Sep 30, 2020
($723.1K)
Nov 4, 2021
Q2
2021
Jun 30, 2020
($305.0K)
Aug 10, 2021